LAZAR MELVIN F
Known title: DirectorCIK: 0001218403
LAZAR MELVIN F's purchase track record
LAZAR MELVIN F has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 11/17/2025 | ABR | $41K | -11.2% | -24.1% | +10.9% |
| 5/12/2022 | ABR | $41K | -1.8% | -5.8% | +0.7% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| ABR | ▲ Buy | Open Market | 5,000 | $41K | 11/17/2025 | View on chart |
| ABR | ▲ Buy | Option Exercise | 7,214 | $0 | 6/30/2023 | View on chart |
| ABR | ▲ Buy | Open Market | 2,500 | $41K | 5/12/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 15, 2026
Arbor Realty Trust faces analyst downgrades and price target cuts
Recent analyst reports have kept Arbor Realty Trust (ABR) in underperform and underweight ratings, with Keefe, Bruyette & Woods and Piper Sandler lowering their price targets to $3 and $3.5 respectively. The stock also recorded a larger decline than the broader market and appears on a list of dividend stocks with unusually high yields. These factors coincide with the share trading near its $5.02 support level and a very low RSI, indicating limited buying pressure.
Arbor Realty Trust faces analyst downgrades and price target cuts. Recent analyst reports have kept Arbor Realty Trust (ABR) in underperform and underweight ratings, with Keefe, Bruyette & Woods and Piper Sandler lowering their price targets to $3 and $3.5 respectively. The stock also recorded a larger decline than the broader market and appears on a list of dividend stocks with unusually high yields. These factors coincide with the share trading near its $5.02 support level and a very low RSI, indicating limited buying pressure.